A bold new idea: can our smartwatches become our personal depression relapse detectors? It's an intriguing concept, and one that new research from McMaster University and the Research Institute of St. Joe's Hamilton is exploring.
The study suggests that these simple wrist-worn devices can detect disruptions in our sleep and daily routines, acting as an early warning system for potential relapses into major depression. This is especially significant for those living with major depressive disorder (MDD), as approximately 60% of them experience relapses within five years, even with treatment.
Dr. Benicio Frey, a professor at McMaster, believes that digital technology and AI algorithms offer great potential for relapse prevention in mental health. He envisions a future where a smartwatch could send an alert: "A new episode of depression is likely within four weeks. Consider reaching out to your healthcare provider."
The study, published in JAMA Psychiatry, followed 93 adults across Canada who had recovered from depression. These participants wore research-grade actigraphy devices, similar to Fitbits or Apple Watches, for one to two years, generating over 32,000 days of sleep and activity data.
The key findings were eye-opening:
- Irregular sleep patterns nearly doubled the risk of relapse.
- The most significant predictor of relapse was the body's ability to differentiate between daytime activity and nighttime rest.
- The amount of time spent awake during the night after initially falling asleep also increased the risk of depression relapse.
- Sleep schedules became more erratic leading up to a relapse.
This research highlights the untapped potential of wearable technology for those recovering from MDD. By passively collecting data, these devices can provide continuous insights between clinical appointments, offering a more proactive approach to mental health monitoring.
Researchers believe this could revolutionize the healthcare system, allowing clinicians to target care more effectively and reduce the burden of recurrent episodes.
MDD is a serious medical condition affecting millions worldwide, impacting their feelings, thoughts, and daily functions. It can cause persistent symptoms like low mood, loss of appetite, feelings of guilt, and a lack of interest in activities.
This study opens up an exciting new avenue for personalizing care for conditions like depression, offering hope and a potential new tool for those living with MDD.
